INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 42 filers reported holding INSMED INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,000 | 0.0% | 8,000 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | 0.0% | 8,000 | 0.0% | 0.00% | – |
| Q3 2021 | $8,000 | -38.5% | 8,000 | -33.3% | 0.00% | – |
| Q2 2021 | $13,000 | +18.2% | 12,000 | +20.0% | 0.00% | – |
| Q1 2021 | $11,000 | -8.3% | 10,000 | -9.1% | 0.00% | – |
| Q4 2020 | $12,000 | +9.1% | 11,000 | +10.0% | 0.00% | – |
| Q3 2020 | $11,000 | -8.3% | 10,000 | -16.7% | 0.00% | – |
| Q2 2020 | $12,000 | +300.0% | 12,000 | +200.0% | 0.00% | – |
| Q1 2020 | $3,000 | -25.0% | 4,000 | 0.0% | 0.00% | – |
| Q4 2019 | $4,000 | +33.3% | 4,000 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | -25.0% | 4,000 | 0.0% | 0.00% | – |
| Q2 2019 | $4,000 | -20.0% | 4,000 | -20.0% | 0.00% | – |
| Q1 2019 | $5,000 | +66.7% | 5,000 | +25.0% | 0.00% | – |
| Q4 2018 | $3,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q3 2018 | $3,000 | -25.0% | 4,000 | 0.0% | 0.00% | – |
| Q2 2018 | $4,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q1 2018 | $4,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 2,974,000 | $2,536,000 | 1.90% |
| Mohican Financial Management, LLC | 500,000 | $422,000 | 1.47% |
| LINDEN ADVISORS LP | 51,146,000 | $43,311,000 | 1.32% |
| ZAZOVE ASSOCIATES LLC | 15,101,000 | $12,810,000 | 1.11% |
| DLD Asset Management, LP | 24,500,000 | $20,911,000 | 1.03% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 31,749,000 | $26,863,000 | 0.55% |
| Cheyne Capital Management (UK) LLP | 1,000,000 | $853,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 6,000,000 | $5,050,000 | 0.39% |
| Jabre Capital Partners S.A. | 1,100,000 | $943,000 | 0.31% |
| Orbimed Advisors | 26,500,000 | $22,611,000 | 0.27% |